Accueil > Santé Naturelle >Santé de la famille >Detoxification > MinciFacil Buvable
MinciFacil Buvable
MinciFacil BuvableMinciFacil BuvableMinciFacil Buvable

MinciFacil Buvable

  • Boisson à diluer dans de l'eau
  • Composé d'actifs naturels
12.90€
Contenance:
En stock En stock
 

MinciFacil est une boisson à diluer dans de l'eau et à consommer tout au long de la journée pour votre bien-être.

Offre de Noël : une bouteille de MinciFacil (500 ml) offerte pour 50 euros d'achats de compléments alimentaires !


Une boisson concentrée à base d'extraits de plantes

La boisson MinciFacil contient les ingrédients suivants : Thé vert, café vert, reine des prés, queues de cerise, citrus aurantium (orange amère), guarana, fève de cacao, persil, écorce de pamplemousse.

Cette boisson minceur est garantie :

  • Sans sucre
  • Sans édulcorant
  • Sans paraben
  • Sans OGM

Elle existe en bouteilles de 500 ml ou 250 ml, qui permettent d'obtenir de 18 à 36 litres de boisson.

La législation Européenne ne nous permettant pas de donner des conseils sur les actifs naturels de ce produit, nous vous invitons à vous renseigner dans la littérature scientifique et à juger par vous-même si l'achat de MinciFacile Boisson peut vous être utile.

Bibliographie d'études mentionnants des éléments présents dans le produit

Source : passeportsante.net

Ces études sont données à titre informatif et ne constituent pas un conseil.

1. FDA US Food and Drug Administration. Drugs – Development and Approval Process - NME Drug and New Biologic Approvals in 2006. [Consulté le 2 juin 2010]. www.fda.gov.

2. A randomized, double-blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts. Gross G, Meyer KG, et al. J. Eur Acad Dermatol Venereol. 2007 Nov;21(10):1404-12.

3. Topical Polyphenon E in the treatment of external genital and perianal warts: a randomized controlled trial. Stockfleth E, Beti H, et al. Br J Dermatol. 2008 Jun;158(6):1329-38. Epub 2008 Mar 20.

4. Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: a randomized controlled trial. Tatti S, Swinehart JM, et al. Obstet Gynecol. 2008 Jun;111(6):1371-9.

5. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Hooper L, Kroon PA, et al. Am J Clin Nutr. 2008 Jul;88(1):38-50.

6. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Nagao T, Hase T, Tokimitsu I. Obesity (Silver Spring). 2007 Jun;15(6):1473-83.

7. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Hsu CH, Tsai TH, et al. Clin Nutr. 2008 Jun;27(3):363-70. Epub 2008 May 12.

8. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Matsuyama T, Tanaka Y, et al. Obesity (Silver Spring). 2008 Jun;16(6):1338-48. Epub 2008 Mar 20.

9. Daily consumption of an aqueous green tea extract supplement does not impair liver function or alter cardiovascular disease risk biomarkers in healthy men. Frank J, George TW, et al. J Nutr. 2009 Jan;139(1):58-62. Epub 2008 Dec 3.

10. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nantz MP, Rowe CA, et al. Nutrition. 2009 Feb;25(2):147-54. Epub 2008 Oct 9.

11. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Brown AL, Lane J, et al. Br J Nutr. 2009 Mar;101(6):886-94. Epub 2008 Aug 19.

12. Purified black tea theaflavins and theaflavins/catechin supplements did not affect serum lipids in healthy individuals with mildly to moderately elevated cholesterol concentrations. Trautwein EA, Du Y, et al. Eur J Nutr. 2010 Feb;49(1):27-35. Epub 2009 Jul 29.

13. Tea catechin consumption reduces circulating oxidized low-density lipoprotein. Inami S, Takano M,et al. Int Heart J. 2007 Nov;48(6):725-32.

17. FDA US Food and Drug Administration. Food – Labeling and Nutrition - Qualified Health Claims: Letter of Denial - Green Tea and Reduced Risk of Cardiovascular Disease (Docket No. 2005Q-0297). [Consulté le 2 juin 2010]. www.fda.gov.

18. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Phung OJ, Baker WL, et al. Am J Clin Nutr. 2010 Jan;91(1):73-81. Epub 2009 Nov 11. Review.

19. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Dulloo AG, Duret C, et al. Am J Clin Nutr. 1999 Dec;70(6):1040-5.

20. Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Westerterp-Plantenga MS, Lejeune MP, Kovacs EM. Obes Res. 2005 Jul;13(7):1195-204.

21. Effectiveness of green tea on weight reduction in obese Thais: A randomized, controlled trial. Auvichayapat P, Prapochanung M, et al. Physiol Behav. 2008 Feb 27;93(3):486-91. Epub 2007 Oct 18.

22. The epidemiology of prostatic cancer. Geographical distribution and time-trends. Muir CS, Nectoux J, Staszewski J. Acta Oncol. 1991;30(2):133-40. Review.

23. Global cancer statistics, 2002. Parkin DM, Bray F, et al. CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108.

24. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Yang CS, Wang X, et al. Nat Rev Cancer. 2009 Jun;9(6):429-39. Review.

26. Green tea consumption and prostate cancer risk in Japanese men: a prospective study. Kurahashi N, Sasazuki S, et al; JPHC Study Group. Am J Epidemiol. 2008 Jan 1;167(1):71-7. Epub 2007 Sep 29.

27. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Jian L, Xie LP, et al. Int J Cancer. 2004 Jan 1;108(1):130-5.

28. No association between green tea and prostate cancer risk in Japanese men: the Ohsaki Cohort Study. Kikuchi N, Ohmori K, et al. Br J Cancer. 2006 Aug 7;95(3):371-3. Epub 2006 Jun 27.

29. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Bettuzzi S, Brausi M, et al. Cancer Res. 2006 Jan 15;66(2):1234-40.

30. The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Seely D, Mills EJ, et al. Integr Cancer Ther. 2005 Jun;4(2):144-55. Review.

31. Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Sun CL, Yuan JM, et al. Carcinogenesis. 2006 Jul;27(7):1310-5. Epub 2005 Nov 25.

32. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Ogunleye AA, Xue F, Michels KB. Breast Cancer Res Treat. 2010 Jan;119(2):477-84. Epub 2009 May 13. Review.

34. Reduced risk of esophageal cancer associated with green tea consumption. Gao YT, McLaughlin JK, et al. J Natl Cancer Inst. 1994 Jun 1;86(11):855-8.

35. Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Sun CL, Yuan JM, et al. Carcinogenesis. 2002 Sep;23(9):1497-503.

36. Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer. Wang LD, Zhou Q, et al. Gan To Kagaku Ryoho. 2002 Feb;29 Suppl 1:159-72.

42. Tea consumption and risk of endometrial cancer: a metaanalysis. Tang NP, Li H, et al. Am J Obstet Gynecol. 2009 Dec;201(6):605.e1-8. Epub 2009 Sep 20.

43. FDA US Food and Drug Administration. Food – Labeling and Nutrition - Letter Responding to Health Claim Petition dated January 27, 2004: Green Tea and Reduced Risk of Cancer Health Claim (Docket number 2004Q-0083) (Docket number 2004Q-0083). [Consulté le 2 juin 2010]. www.fda.gov.

44. Effect of cocoa and tea intake on blood pressure: a meta-analysis. Taubert D, Roesen R, Schömig E. Arch Intern Med. 2007 Apr 9;167(7):626-34.

51. Santé Canada. Médicaments et produits de santé – Extraits de thé vert. Gouvernement du Canada. [Consulté le 2 juin 2010]. www.hc-sc.gc.ca.

52. Santé Canada. Médicaments et produits de santé – Bulletin canadien des effets indésirables. Gouvernement du Canada. [Consulté le 2 juin 2010]. www.hc-sc.gc.ca.

53. The acute effects of L-theanine in comparison with alprazolam on anticipatory anxiety in humans. Lu K, Gray MA, Oliver C, Liley DT, Harrison BJ, Bartholomeusz CF, Phan KL, Nathan PJ. Hum Psychopharmacol. 2004 Oct;19(7):457-65.

54. L-theanine, a natural constituent in tea, and its effect on mental state. Nobre AC, Rao A, Owen GN. Asia Pac J Clin Nutr. 2008;17 Suppl 1:167-8.

55. L-Theanine reduces psychological and physiological stress responses. Kimura K, Ozeki M, Juneja LR, Ohira H. Biol Psychol. 2007 Jan;74(1):39-45.

56. Specific formulation of Camellia sinensis prevents cold and flu symptoms and enhances gamma,delta T cell function: a randomized, double-blind, placebo-controlled study. Rowe CA, Nantz MP, et al. J Am Coll.Nutr 2007;26(5):445-452.

 

1. Haaz S, Fontaine KR, et al. Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes Rev. 2006 Feb;7(1):79-88.

2. Bent S, Padula A, Neuhaus J. Safety and efficacy of citrus aurantium for weight loss. Am J Cardiol. 2004 Nov 15;94(10):1359-61. Review.

3. Fugh-Bergman A, Myers A. Citrus aurantium, an Ingredient of Dietary Supplements Marketed for Weight Loss : Current Status of Clinical and Basic Research, Experimental Biology and Medicine. Exp Biol Med (Maywood). 2004 Sep;229(8):698-704. Texte intégral : www.ebmonline.org

4. Potential applications for alternative medicine to treat obesity in an aging population. Cherniack EP.Altern Med Rev. 2008 Mar;13(1):34-42. Review. Texte intégral : www.thorne.com

5. Hedrei P, Gougeon R. Thermogenic effect of beta sympathicomimetic compounds extracted from Citrus aurantium. McGill Nutrition and Food Science Center, Royal Victoria Hospital : Canada, 1997 (report). Rapport cité et résumé dans la synthèse de la note 1.

6. Pathak B, Gougeon R. Thermic effect of Citrus aurantium in obese subjects. Current Therapeutic Res 1999; 60: 145–151. Étude citée et résumée dans la synthèse de la note 1.

7. Sale C, Harris RC, et al. Metabolic and physiological effects of ingesting extracts of bitter orange, green tea and guarana at rest and during treadmill walking in overweight males. Int J Obes (Lond). 2006 May;30(5):764-73.

8. Effects of limonene and essential oil from Citrus aurantium on gastric mucosa: role of prostaglandins and gastric mucus secretion. Moraes TM, Kushima H, et al. Chem Biol Interact. 2009 Aug 14;180(3):499-505.

9. Essential oils and anxiolytic aromatherapy. Setzer WN. Nat Prod Commun. 2009 Sep;4(9):1305-16.

10. Behavioral effects of essential oil of Citrus aurantium L. inhalation in rats. Leite MP, Fassin J,et al. Brazilian Journal of Pharmacognosy. Dez. 2008 18 (Supl.), 661-666. Texte intégral : www.scielo.br

11. Effects of the essential oil from Citrus aurantium L. in experimental anxiety models in mice. Pultrini Ade M, Galindo LA, Costa M. Life Sci. 2006 Mar 6;78(15):1720-5.

12. Effects of Juniper and Bergamot Essential Oils on Anxiety and Methamphetamine Reward in Mice. Tu CH. M.S. Thesis, National Cheng Kung University, Taiwan, ROC, 2003.

13. Anxiolytic and sedative effects of extracts and essential oil from Citrus aurantium L. (a) Carvalho-Frietas MIR, Costa M. Biol Pharm Bull. 2002 Dec;25(12):1629-33. Texte intégral : www.jstage.jst.go.jp

14. Ramadan W, Mourad B, et al. Oil of bitter orange: new topical antifungal agent. Int J Dermatol. 1996 Jun;35(6):448-9.

15. Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement. Sultan S, Spector J, Mitchell RM. Mayo Clin Proc. 2006 Dec;81(12):1630-1. Texte intégral : www.mayoclinicproceedings.com

16. Variant angina associated with bitter orange in a dietary supplement. Gange CA, Madias C, et al.Mayo Clin Proc. 2006 Apr;81(4):545-8. Texte intégral : www.mayoclinicproceedings.com

17. Santé Canada. Orange amère ou synéphrine : mise à jour sur les effets indésirables cardiovasculaires. Bulletin canadien des effets indésirables, Volume 17 - numéro 2 - avril 2007. [Consulté le 19 novembre 2009] www.hc-sc.gc.ca

18. Santé Canada. Santé Canada met en garde les Canadiens contre l'utilisation du « Thermonex », 28 mai 2004 [Consulté le 23 octobre 2009] www.hc-sc.gc.ca

19. Bouchard NC, Howland MA, et al. Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine.Mayo Clin Proc. 2005;80:541-5. Texte intégral : www.mayoclinicproceedings.com

20. Coronary spasm and thrombosis in a bodybuilder using a nutritional supplement containing synephrine, octopamine, tyramine and caffeine. Smedema JP, Müller GJ. S Afr Med J. 2008 May;98(5):372-3. No abstract available. Résumé : www.sabinet.co.za

21. Bui LT, Nguyen DT, Ambrose PJ. Blood pressure and heart rate effects following a single dose of bitter orange. Ann Pharmacother. 2006 Jan;40(1):53-7.

22. Min B, Cios D, et al. Absence of QTc-interval-prolonging or hemodynamic effects of a single dose of bitter-orange extract in healthy subjects. Pharmacotherapy. 2005 Dec;25(12):1719-24.

23. Haller CA, Benowitz NL, Jacob P 3rd. Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med. 2005 Sep;118(9):998-1003.

24. Human pharmacology of a performance-enhancing dietary supplement under resting and exercise conditions. Haller CA, Duan M et al. Br J Clin Pharmacol. 2008 Jun;65(6):833-40.

25. Malhotra S, Bailey DG, et al. Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin Pharmacol Ther 2001;69:14-23.

26. Edwards DJ, Fitzsimmons ME, et al. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther. 1999 Mar;65(3):237-44.

27. Mitchell Dave. Synephrine, a bitter pill to swallow, 2008. [Consulté le 23 octobre 2009] www.davesworkout.com

1. M. Westerterp-Plantenga, K. Diepvens, A. M. C. P. Joosen, S. Berube-Parent, and A. Tremblay, “Metabolic effects of spices, teas, and caffeine,” Physiology & Behavior, vol. 89, no. 1, pp. 85–91, 2006.
2. A. T. Roberts, L. de Jonge-Levitan, C. C. Parker, and F. Greenway, “The effect of an herbal supplement containing black tea and caffeine on metabolic parameters in humans,” Altern Med Rev, vol. 10, no. 4, pp. 321–325, 2005. 
3. S. Bérubé-Parent, C. Pelletier, J. Doré, and A. Tremblay, “Effects of encapsulated green tea and Guarana extracts containing a mixture of epigallocatechin-3-gallate and caffeine on 24 h energy expenditure and fat oxidation in men,” Br. J. Nutr., vol. 94, no. 3, pp. 432–436, 2005.
4. European Scientific Cooperative on Phytotherapy, ESCOP Monographs - The Scientific Foundation for Herbal Medicinal Products, 2è édition, supplément., vol. 1. Nex York: Thieme, 2009.

 

Vous aimerez aussi

Les internautes ayant achete cet article ont egalement achete :

Poudre de Fucus
Prix 11.00 €
 
Trustpilot